An Integrated Surveillance System to Examine Testing, Services, and Outcomes for Sexually Transmitted Diseases by Dixon, Brian E. et al.
An Integrated Surveillance System to Examine Testing, 
Services, and Outcomes for Sexually Transmitted Diseases 
Brian E. Dixona,b, Guoyu Taoc, Jane Wangb, Wanzhu Tub,d, 
Sarah Hooverb, Zuoyi Zhangb, Teresa A. Batteigerd, Janet N. Arnod 
a Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA,  
b Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana, USA 
c Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA 
d Indiana University School of Medicine, Indianapolis, Indiana, USA 
 
Abstract 
Despite laws that require reporting of sexually transmitted 
diseases (STDs) to governmental health agencies, integrated 
surveillance of STDs remains challenging. Data and 
information about testing are fragmented from information on 
treatment and outcomes. To overcome this fragmentation, 
data from multiple electronic systems spanning clinical and 
public health environments were integrated to create an STD 
surveillance registry. Electronic health records, disease case 
records, and birth registry records were linked and then 
stored in a de-identified, secure server for use by health 
officials and researchers. The registry contains nearly 6 
million tests for 628,138 individuals over a 12-year period. 
The registry supports efforts to understand the epidemiology 
of STDs as well as health services and outcomes for those 
diagnosed with STDs. Specialized disease registries hold 
promise for collaboration across clinical and public health 
domains to improve surveillance efforts, reduce health 
disparities, and increase prevention efforts at the local level. 
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Introduction 
Sexually Transmitted Diseases (STDs) 
Undiagnosed and untreated sexually transmitted disease 
(STD) is associated with adverse outcomes such as infertility, 
increased HIV transmission and acquisition, and adverse 
pregnancy outcomes. Several STD health services are 
recommended by the Centers for Disease Control and 
Prevention (CDC) to protect the reproductive and sexual 
health of young men and women. Recommendations include: 
annual chlamydia and gonorrhea screening of sexually active 
women ≤24 years, pregnant women, and older at-risk women; 
chlamydia and gonorrhea screening of anatomic sites of 
exposure (urethral, rectal, or pharyngeal) of men who have sex 
with men (MSM); retesting of all infected persons after 
treatment for chlamydia or gonorrhea; and syphilis testing of 
pregnant women as well as sexually active MSM [1]. 
Surveillance of STDs and STD Services 
A core function of public health is the assessment of disease 
prevalence and burden as well as the utilization of health care 
services, also referred to as public health surveillance [2]. 
Ministries around the globe seek to perform surveillance on 
STDs as well as the utilization of STD health services. They 
further seek to monitor the quality of health services received 
by at-risk groups, assess adherence to recommendations for 
chlamydia and gonorrhea testing and retesting, syphilis 
testing, test results, patient and partner treatment, and the 
incidence of adverse outcomes related to STDs.  
Assessing STD prevalence, burden and utilization of health 
services is challenging, because available data sources are 
limited by small sample sizes, incomplete demographic 
information, cross-sectional design, insufficient periods of 
follow-up time, and incomplete information about the services 
provided [3]. Access to a longitudinal data source with 
complete demographic and clinical information for individual 
patients is challenging for public health agencies and 
researchers, especially in the United States, given the 
fragmented delivery of care in public and private settings. 
Furthermore, there are even fewer data sources that capture an 
entire geographic community as opposed to a population 
defined by a single institution that provides care or insurance 
(such as a managed care population). While data sources such 
as population health surveys provide partial information, none 
have been able to provide all the information required to 
assess community access, utilization and quality of services, 
and the incidence of adverse outcomes following an STD. 
Specialized Disease Registries 
Centralized data registries have become important informatics 
tools for surveillance and research in a variety of public health 
contexts, including cancer treatment [4], immunization 
programmes [5], and injury prevention [6]. In fact, expanded 
health policies in the United States, referred to as “meaningful 
use” criteria for electronic health record (EHR) systems, 
include disease registries as a ‘public health’ criterion for the 
years 2013-2018 [7]. These policies encourage providers to 
submit patient-level information to specialized registries. 
Once populated, disease registries can be reused for a variety 
of purposes, including clinical performance improvement, 
surveillance of disease incidence, and research on the 
utilization of health services [8; 9]. In essence, disease 
registries serve as integrated surveillance systems that support 
a wide range of clinical and public health functions. 
Research Objective 
Given the need for better community-level surveillance of 
STDs and STD health services as well as the past success of 
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other population disease registries, we sought to develop a 
longitudinal, comprehensive patient-centric registry to 
examine STDs and STD health services in a large 
metropolitan area. We hypothesized that the registry would 
support analysis of STDs and STD services as well as ongoing 
surveillance practice among public health agencies in that 
community. 
Methods 
We created a registry for all individuals tested for one of three 
STDs (chlamydia, gonorrhea, syphilis) between January 1, 
2003, and December 31, 2014, by healthcare providers in the 
Indianapolis MSA (metropolitan statistical area). To create the 
registry, we gathered data from clinical and public health 
sources, linked individual patient records, and created a secure 
environment to facilitate collaborative access for surveillance 
and research. Our work occurred in partnership with local, 
state, and federal public health partners and was approved by 
the Institutional Review Board (IRB) at Indiana University.  
Geography and Population Information 
According to the 2010 census,  Indiana ranked 15th among the 
states by population with just under 6.5 million residents. 
Consistent with national data, STDs are over-represented in 
racial and ethnic minorities (cases per 100,000 population). 
For example, the 2015 rate of gonorrhea among African 
Americans was 836 compared to the rate among Caucasian 
87.7 and Hispanic individuals 85.0. The rates for chlamydia 
were 2234 for African Americans, 319 for Caucasians, and 
545 for Hispanics for primary and secondary syphilis (26.8, 
6.6 and 16.6, respectively).   
The Indiana State Health Department (ISDH) STD Control 
Program divides the state’s 92 counties into ten districts for 
morbidity reporting and disease intervention purposes. These 
district offices are the recipients of contracts with the STD 
Program for the state’s approximately 30 disease intervention 
specialists. The Marion County Public Health Department 
(MCPHD) STD Control Program has responsibility for STD 
reporting in District 5, which includes Marion County 
(Indianapolis) and the seven surrounding counties: Boone, 
Hamilton, Hancock, Hendricks, Johnson, Morgan, and Shelby. 
This district makes up the majority of the Indianapolis MSA. 
District 5 (population of 1.7 million) and Marion County 
(population of 903,393) account for the largest share of 
Indiana’s STD morbidity. In 2015, District 5 accounted for 
39% of the state’s chlamydia morbidity, 47% of the state’s 
gonorrhea, and 60% of the state’s primary and secondary 
syphilis. This partially reflects the district’s racial health 
disparities, which is substantially more diverse than the state. 
According to the CDC’s 2015 STD Surveillance Report, 
Indiana reported a total of 28,886 cases of chlamydia and 
ranked 27th among states in rate (437.9/100,000), while 
Marion County ranked 25th among United States counties and 
independent cities at 949.3 cases/100,000 population.  Indiana 
ranked 23th among states for gonorrhea with a case rate of 
118.9/100,000 population, while Marion County ranked 16th 
among United States counties and independent cities in the 
rate of gonorrhea cases with 344.1 cases/100,000 population.  
Residents of District 5 receive STD diagnostic and treatment 
services through the Bell Flower Clinic, the STD Control 
program of MCPHD, which also houses the District 5 
reporting site. The program is operated by the Health and 
Hospital Corporation, which also operates MCPHD and safety 
net hospital for the county. The Bell Flower Clinic, therefore, 
serves those at highest risk. Of the unique patients at the Bell 
Flower Clinic, 57% were African-American, 33% were 
Caucasian, and 7% were other. Seven percent were Hispanic, 
mostly of Mexican descent. 
Data Sources 
Data for the registry came from three distinct sources: 
1. The Indiana Network for Patient Care (INPC), a 
regional health information exchange (HIE) network 
that contains longitudinal EHRs for patients who 
received care in the Indianapolis MSA. 
2. MCPHD Bell Flower Clinic, the STD Control Program 
which houses an information system where disease 
investigators enter details about STD cases reported to 
public health for the Indianapolis MSA. 
3. MCPHD Birth Registry, a vital records information 
system used at MCPHD to capture data on all births in 
Marion County, in which Indianapolis is located. 
 Figure 1 – Diagram depicting data sources, how data are 
integrated, and how data are accessed for surveillance 
 
Indiana Network for Patient Care 
The INPC is one of the largest community-based HIE 
networks in the United States [10; 11]. The INPC connects 
over 90 healthcare facilities, including hospitals, physicians’ 
practices, pharmacy networks, long-term post-acute care 
facilities, laboratories, and radiology centers. The INPC 
maintains over five billion structured observations for over 12 
million individuals; nearly one million electronic healthcare 
transactions are processed every day. 
From the INPC, we extracted demographic data (e.g., gender, 
age, race, county of residence), STD laboratory testing data 
(e.g., lab test, date of test, result), co-morbidity data (e.g., 
pregnancy status, HIV status, ICD diagnoses) at time of STD 
test, encounter data (e.g., visit date, visit type), and medication 
history (e.g., drug name, drug class, date of dispense). 
MCPHD Bell Flower Clinic and ISDH Morbidity Data 
From the files at the Bell Flower Clinic, we extracted 
demographic data (e.g., gender, age, race), STD laboratory 
testing data (e.g., lab test, date of test, result), co-morbidity 
data (e.g., pregnancy status, HIV status) at time of the STD 
test, and medication information (e.g., drug name, drug class, 
date of dispense).  
Because STD treatment may not be fully captured by the 
INPC, we extracted treatment of STD morbidity information 
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from the ISDH reporting database, SWIMSS (Statewide 
Investigating, Monitoring and Surveillance System).  
MCPHD Birth Registry 
The MCPHD Birth Registry contains records on all live births 
in hospitals and birthing centers in Marion County as reported 
by birth registrars. From the birth registry, we extracted 
pregnancy outcomes (e.g., date of delivery, infant weight, 
gestational age), STD laboratory testing data (e.g., lab test, 
date of test, result), and co-morbidity data (e.g., HIV status) at 
time of delivery. 
Record Linkage, Integration, and Preparation 
Data were integrated from the three distinct sources using a 
two-step process (Figure 1). First, individuals were linked 
across datasets. Next, data from each source was extracted and 
combined into a single, patient-centric data registry. 
The INPC employs an advanced, probabilistic matching 
algorithm that matches patient identities using first name, last 
name, social security number (when available), date of birth, 
phone number (when available), and gender [12]. The two 
MCPHD datasets were independently linked to the INPC 
using the enterprise master person index (eMPI), based on that 
algorithm. Individuals in the MCPHD STD Case and 
Morbidity Files who did not match to an INPC individual 
were imported into the registry as new clients. Only data for 
individuals in the MCPHD Birth Registry who matched an 
INPC individual were imported from the vital records system. 
Once patient identities were linked, longitudinal data for each 
unique individual were extracted, transformed, and loaded 
from the three sources into the registry. Each unique 
individual was given a de-identified or pseudonymised “client 
ID” that did not resemble his/her medical record number or 
any identifiers in the MCPHD datasets. Birth dates were 
transformed to ages and other identifiable information was 
removed. The ability to re-identify individuals exists to enable 
capture of new and updated information using a key between 
the medical record number and the client ID. Only the data 
manager at Regenstrief can perform data updates. Registry 
users cannot access such details to ensure confidentiality of 
records. 
Data Management 
The deidentified, linked registry datasets are hosted on a 
secure, virtual server at the Regenstrief Institute (Figure 1). 
The encrypted server is password-protected and managed by 
the technical services division at Indiana University (IU). The 
datasets are stored as a collection of interoperable data files, 
enabling them to be interpreted by all major analytical 
software tools. The data files require 20GB disk space. 
Authorized users include public health scientists at the CDC 
and MCPHD as well as scientists working at Regenstrief and 
IU. The virtual environment affords users the opportunity to 
leverage a wide range of analytical tools, including SAS, R, 
and SPSS. Analyses of the data can be performed within the 
IU high-performance computing environment without 
necessitating download of the data onto local computers or 
drives. Output from the analyses, such as tables, charts, and 
graphs, can be downloaded from the servers to support in 
public health or academic reports. 
Results 
The registry contained 5,093,863 STD tests for 628,138 
unique individuals collected over a 12-year period. In Table 1, 
we present the demographics of the individuals who were 
tested and those who tested positive for an STD in comparison 
to the overall demographics for the Indianapolis MSA. 
Although the area was well-balanced with respect to gender, a 
greater proportion of females were tested for STDs. This is 
likely due to clinical guidelines that recommend screening 
pregnant women and young, sexually active women for STDs. 
African American individuals were proportionately tested 
more and had a greater proportion of disease, than other races. 
These data highlight both a racial disparity in disease burden 
as well as the fact that providers are more regularly screening 
this population. 
Table 1 – Demographics for individuals in the registry 
Demo-graphic 
Individuals 
Tested for 
an STD 
N=628,138 
Individuals 
Positive for an 
STD 
N=119,751 
Population of 
the MSA 
 
N=1,988,817 
Gender    
Male 17.5% 25.3% 49.3%
Female 82.4% 74.6% 50.7%
Race    
African-American 25.0% 61.9% 15.3%
Caucasian 48.2% 25.1% 79.2%
Asian 0.4% 0.2% 2.9%
Hispanic 3.4% 2.7% 6.5%
Age    
5-17  10.4% 18.3%
18-24  40.0% 8.8%
25-44  25.8% 27.6%
 
In Figure 2, we summarize test results and positivity over time 
across all three STDs. Positivity is defined as the number of 
positive laboratory tests that confirm the presence of disease 
divided by the total number of lab tests analyzed. The overall 
volume of tests captured by the registry increased through 
2011 then plateaued as result of the growth in the contributing 
data sources to the INPC from providers joining the HIE 
network to comply with ‘meaningful use’ incentives. Growth 
in the volume of data captured by the INPC resulted in 
decreased positivity; the number of negative tests grew by a 
factor of 3, while the number of positive tests increased by a 
factor of 2.5 (from 10,044 in 2003 to 25,606 in 2014). While 
the total number of positive STD cases grew dramatically, this 
growth is attributed to increased electronic lab reporting rather 
than an outbreak of disease.  
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 Figure 2 – Longitudinal test results and positivity for 
chlamydia, gonorrhea and syphilis. Test results are depicted 
as bars; positivity is depicted as a trend line 
Discussion 
By integrating three disparate sources of routinely collected 
clinical and public health data, we have created a novel 
registry containing longitudinal data on individuals tested for 
STDs in a large metropolitan area. The STD registry is an 
important public health informatics resource as it affords 
surveillance and research on STD testing, services, and 
outcomes. While each data source may exist independently in 
states and nations around the world, very rarely are EHR 
systems, vital records, and STD morbidity files linked and 
used to examine those tested or treated for STDs.  
Most often, health departments only have access to positive 
laboratory results, which are required by law to be reported to 
health authorities [13]. While electronic laboratory reporting 
of positive test results improves the completeness and 
timeliness of public health reporting [14; 15], the lack of 
negative test reporting prevents health departments from 
examining whether individuals at risk for STDs are receiving 
recommended screening. Moreover, while health departments 
maintain both STD morbidity and vital record information 
systems, many health departments fail to link these data to 
examine outcomes for pregnant women or populations at risk 
for poor birth outcomes. Therefore, integrating clinical and 
public health datasets allows for an expanded evaluation of 
preventative services, clinical guidelines, and outcomes 
experienced by those with STDs. 
Our work demonstrates the feasibility of creating a specialized 
STD registry for conducting surveillance and research. 
Building the registry further highlights three lessons for the 
biomedical and public health informatics communities. First, 
specialized registries that cross clinical and public health 
boundaries can be created in a way that preserves privacy and 
confidentiality. Second, record linkage is a crucial aspect of 
creating a registry. Third, health IT policies affect the breadth 
and depth of specialized registries. 
Maintaining Privacy and Confidentiality of Health Data 
Individuals and health organizations can be fearful of 
centralized, monolithic databases that contain protected health 
information [16]. Therefore, healthcare providers may be wary 
of releasing identifiable information to public health 
authorities, except when required by law to do so. 
To create our registry, we leveraged the Regenstrief Institute, 
a neutral third party with experience in protecting health data. 
Regenstrief is a business associate with healthcare providers, 
public health authorities, and the INPC [11]. As a convening, 
trusted partner, the Institute was able to bring clinical and 
public health organizations together to exchange identifiable 
data that could be linked and then de-identified for storage in a 
secure, common environment that affords surveillance and 
research by multiple users. The role of neutral third parties is 
supported by prior HIE research [17]; therefore, public health 
authorities should look to HIE networks or other third parties 
to support creating and maintaining specialized registries. 
The Critical Role of Data Linkage 
One of the most important and challenging aspects of creating 
the registry was record linkage. Linkage is important because 
uniquely identifying individuals is critical to pulling 
fragmented EHRs together for tracking an individual’s STD 
testing and services longitudinally. 
Because the original data sources independently maintain 
distinct, unique identifiers for individuals and the United 
States lacks a universal health identifier, there was no easy 
method to link individuals at the start of the project. While the 
probabilistic algorithm used by the INPC’s eMPI is excellent, 
it is not flawless. Therefore, each public health source had to 
be independently matched to the INPC, and then the two 
matched sets had to be linked using a third round of matching. 
Due to the lack of universal identifiers, each round of 
matching involved some degree of manual review and a 
decision threshold for determining correct matches had to be 
established. The necessity of manual review prohibits 
automation and scaling of specialized registry creation. 
One potential solution for others is a client registry (CR) [18]. 
A CR adjudicates identities across EHR and other health data 
systems, like vital records and morbidity information systems, 
producing a centralized MPI to link identities across data 
sources. CRs have been demonstrated in HIE networks 
emerging in several countries, including Rwanda [19]. The CR 
should be further studied and applied to specialized disease 
registries. 
Robust Policies Facilitate Specialized Registries 
The STD registry is but one example of a specialized health 
data registry. While a wide range of registries for injuries, 
vaccines, and diabetes existed before the HITECH (Health 
Information Technology for Economic and Clinical Health) 
Act of 2009, the “meaningful use” program’s incentive for 
clinical providers to contribute data to a specialized registry 
encourages clinical-public health data exchange. Local health 
authorities struggle to receive data that are currently not 
covered under existing public health laws. While new laws 
can be written to require data exchange, health authorities 
have an opportunity to leverage existing policies, like 
HITECH, to work with clinical providers to create and sustain 
population health surveillance through specialized registries. 
When creating registries, health authorities should consider 
the unique health needs of their jurisdiction. Community 
health assessments, an activity involving the gathering of 
input from a wide array of stakeholders on the important 
issues facing a community, are another opportunity to work 
with healthcare providers to identify key health issues that 
might benefit from a specialized disease registry. Diabetes 
may be a top priority in one nation, while hypertension might 
be a top priority in another jurisdiction. Working with 
healthcare providers to identify the health priorities of a 
community may lead to better participation in the registry as 
well as progress in “moving the needle” towards higher 
quality of care and outcomes for at-risk populations. 
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Future Directions for the STD Registry 
The STD registry allows our team to explore many important 
questions relevant to public health practice and research. Our 
team is currently conducting the following analyses and plans 
to disseminate results in the coming year: 
• Utilization of STD Services:  Understanding where 
individuals present for STD services is critical for 
appropriately allocating available resources. Using 
the data available within the registry, we are 
examining testing locations and positivity rates of 
individuals to determine where individuals present 
for STD care and whether a positive result increases 
the likelihood of presenting to a specific location. 
• Testing and Outcomes for Pregnant Women: Women 
should be screened and treated for STDs while 
pregnant. Using the available testing data for women 
who either tested positive for pregnancy or delivered 
a baby, we are examining the proportion who 
received an STD test; of those, which women were 
positive and the birth outcomes for women who 
tested positive. 
In addition, we seek to expand the capacity for the registry to 
support other research and surveillance of STD testing, 
services, and outcomes. In the next year, we plan to link the 
registry to other unique public health datasets, including the 
Immigrant Tuberculosis and All Refugee Application 
(ITARA) database. This database includes information on 
Indiana state immigrant medical exams. Incorporating these 
data will facilitate an analysis of newly immigrated citizens 
for incidence as well as risk factors associated with STDs. The 
registry will continue to be hosted at Regenstrief for use by 
public health researchers as well as epidemiologists in local, 
state, and federal agencies. 
Conclusion 
Using multiple data sources, we successfully linked and 
integrated data relevant to the testing, treatment, and outcomes 
for individuals with STDs to create a specialized STD registry. 
Registries like this one are increasingly feasible to build using 
informatics approaches. Specialized disease registries are 
critical to understanding the epidemiology of disease and 
enable collaboration across clinical and public health domains 
to improve surveillance, reduce health disparities, improve 
health services for individuals with disease, and increase 
prevention efforts at the local level. 
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